Skip to main navigation
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • Tango
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • Rett Syndrome
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
    • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
Stoke Therapeutics
  • Contact Us
  • LinkedIn
  • Twitter
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • Tango
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • Rett Syndrome
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
    • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
  • Home
  • Investors & News
  • Financials & SEC Filings
  • SEC Filing Details

SEC Filing Details

Document Details

Form
UPLOAD
Filing Date
April 17, 2019
Document Date
April 17, 2019
Form Description
UPLOAD
Filing Group
Other
Company
Stoke Therapeutics
Issuer
Stoke Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Print Page
Email Alerts
Contact IR
Investor FAQs
  • About Stoke
  • Scientific Platform
  • Disease Areas
  • Patients & Families
  • Careers & Culture
  • Investors & News
  • Contact Us
Stoke Logo

© 2023 Stoke Therapeutics, all rights reserved.

  • Privacy Policy
  • Terms of Use
  • Site Map
  • LinkedIn
  • Twitter